Announcements Trials
Browse Landscape

Phase

Phase 2 8Phase NA 5Phase 3 3Phase 2/3 2Phase 1/2 2Phase EARLY_PHASE1 1Phase 1 1

Status

Withdrawn 1Completed 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Breast 2

Conditions

Breast Neoplasms 2Glioblastoma 1Carcinoma, Intraductal, Noninfiltrating 1Biomarker Change Linked to Breast Cancer 1

Interventions

Trastuzumab 62Paclitaxel 57Cyclophosphamide 44pembrolizumab 34Fulvestrant 34Capecitabine 29Carboplatin 26Docetaxel 23Letrozole 22Doxorubicin 19palbociclib 16abemaciclib 16pertuzumab 15durvalumab 14Filgrastim 13Everolimus 13ribociclib 12Lapatinib 12Gemcitabine 12exemestane 11eribulin 11Vinorelbine 11Albumin-Bound Paclitaxel 11Bevacizumab 10trastuzumab deruxtecan 9neratinib 9fludarabine 9Taxes 9Radiotherapy 9Peripheral Blood Stem Cell Transplantation 9

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase 1/2 × Breast Neoplasms × Cholecalciferol × Clear all
NCT02856503 2026-04-17

Effect of High Dose Vitamin D on Cancer Biomarkers and Breast Cancer Tumors

University of Miami

Phase 1/2 Withdrawn
Breast

Breast Neoplasms, Carcinoma, Intraductal, Noninfiltrating

NCT01425476 2017-08-09

Changes in Breast Cancer Biomarkers Using Synergistic Prostaglandin Inhibitors

Hartford Hospital

Phase 1/2 Completed
45 enrolled
Breast

Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡